Yanfei Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Aberrant activation of epigenetic BRD9-DGAT1 axis promotes lipid droplets deposition and ferroptosis resistance in YAP-high prostate cancer.
Journal: Cell death & disease
Published: June 27, 2025
Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.
Journal: Signal transduction and targeted therapy
Published: April 30, 2025
Clinical outcomes of modified partial cystectomy in muscle-invasive bladder cancer: balancing tumor control and quality of life.
Journal: Translational andrology and urology
Published: March 31, 2025
Multidimensional investigation of thyroid hormones and prostate cancer: insights from NHANES, Mendelian randomization, genetic markers, and bioinformatics analyses.
Journal: Discover oncology
Published: January 23, 2025
Purine Nucleoside Phosphorylase (PNP) as a Biomarker and Therapeutic Target in Muscle-Invasive Bladder Cancer.
Journal: Clinical Medicine Insights. Oncology
Published: January 01, 2025
L-shaped association between the ratio of serum albumin to globulin and the risk of all-cause mortality among adults with kidney stones: a national cohort study.
Journal: Translational andrology and urology
Published: October 25, 2024
Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis.
Journal: Frontiers in oncology
Published: July 30, 2021
HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer.
Journal: Molecular therapy. Nucleic acids
Published: January 17, 2021
Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial-Mesenchymal Transition.
Journal: Frontiers in cell and developmental biology
Published: December 14, 2020
TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis.
Journal: Frontiers in oncology
Published: November 23, 2020
Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Journal: Cell proliferation
Published: June 19, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026